Immunotherapy - Publications - Faculty & Research

2024
Working Paper

Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances

In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details

Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms

Citation

SSRN

Read Now

28 Nov 2016
News

One Obstacle to Curing Cancer: Patient Data Isn’t Shared

Web

Faculty & Advisors | MBA

immunotherapy strategy which ultimately guided Celgene into the rapidly developing field of immuno-oncology (IO). Kareem started his career at Vertex Pharmaceuticals in formulation development. Mark Robinson MBA ‘93, Harvard University;... View Details

22 Feb 2024
News

Combat-Tested Cancer Coaching

think I'll just rest on my laurels and see what happens now. I was equally as tenacious about finding the next immunotherapy drug that might come out. And so I think that balance was out of whack. I was so focused on that urgency. On the... View Details

Web

Profiles - MBA

operators to overcome scientific and strategic challenges and break the boundaries of medicine. Moreover, I conduct research on improving immunotherapies for solid tumors in the translational Mitrogotri Lab at Harvard SEAS, and co-founded... View Details

15 Jan 2018
Research & Ideas

A Better Business Model for Fighting Cancer

therapies has become a reality, as have immunotherapies that induce or suppress a body’s immune response to treat disease. Yet, this relatively swift progress has not been fast enough for millions of other patients who still lack... View Details

Keywords: by Julia Hanna; Health; Pharmaceutical

Publications